Artificial Intelligence Systems for Diabetic Retinopathy Screening: Appraisal on the 3rd US FDA Approved Algorithms- AEYE-DS

Journal Title: Journal of Ophthalmology and Advance Research - Year 2023, Vol 4, Issue 2

Abstract

Artificial Intelligence (AI) has revolutionized the field of healthcare in recent years, and one of its most promising applications is on the interpretation of medical images [1]. In ophthalmology, the first success comes to the screening and diagnosis of Diabetic Retinopathy (DR) [2]. DR is a common complication of Diabetes Mellitus (DM) that affects the eyes, and early detection and treatment is crucial in preventing vision loss, especially over the working populations [3]. The use of AI in DR screening involves analyzing digital fundus images to detect any signs of DR, including microaneurysms, dot and blot haemorrhages, cotton-wool spots, venous beading, intraretinal microvascular anomalies [4]. Currently, there are 3 US FDA approved systems on DR screening, IDx-DR (Digital Diagnostics), EyeArt (Eyenuk, Inc) and AEYE-DS (AEYE Health, Inc) [5-7]. AI has several advantages over traditional screening methods, including usage by non-ophthalmologically trained medical personnel, accessible and stable performance over whatever time and place, increased speed of clinical workflow, these might potentially help to improve outcomes for patients with DM. In the era of rapidly advancing technology, the use of AI in ophthalmology is an exciting development that might transform our future practice [8]. In this appraisal, we focus on the 3rd US FDA approved AI algorithms for DR.

Authors and Affiliations

Vanessa, Ching Chi Lee, Sunny Chi Lik Au

Keywords

Related Articles

Cataract Surgery with Systemic Diseases: Is Perioperative Management Necessary?

Background: Cataract Surgery is commonly done surgery in the geriatric age group. These patients may have several systemic diseases to which adequate attention must be paid during surgical planning, local anesthesia ad...

Linkage of Diabetic Retinopathy with Blood Antioxidants and Gut Microbiota in Type Two Diabetes Mellitus Saudi Patients

Background: The retina is a light-sensitive nerve layer located at the back of the eye that creates images of objects. These cells kept alive by getting oxygen and nutrients from tiny blood vessels in the eye. Retinopath...

Myopia and Environmental Risk Factors: A Comprehensive Study

Background: The global rise in the prevalence of myopia calls for evidence-based strategies to be devised to reduce the incidence and delay the progression of Myopia. The aim is to determine the relationship between myop...

Manifestations and Treatment of Ocular Coccidioidomycosis: A Review of Literature

Purpose of Review: This review aims to summarize the epidemiology, manifestations and treatment of ocular coccidioidomycosis, a rare yet significant fungal infection that can severely impair vision. Recent Findings: “...

Oily Multifocal IOL

A 58 year old male operated for cataract surgery implanted with a multifocal Intraocular Lens (IOL), later underwent vitreoretinal surgery for retinal detachment with silicone oil injection. Even after removal of silic...

Download PDF file
  • EP ID EP718833
  • DOI https://doi.org/10.46889/JOAR.2023.4202
  • Views 54
  • Downloads 0

How To Cite

Vanessa, Ching Chi Lee, Sunny Chi Lik Au (2023). Artificial Intelligence Systems for Diabetic Retinopathy Screening: Appraisal on the 3rd US FDA Approved Algorithms- AEYE-DS. Journal of Ophthalmology and Advance Research, 4(2), -. https://europub.co.uk./articles/-A-718833